Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Briacell Therapeutics Corp

(TSX-V: BCT.VN)
Add to Portfolio
-0.015 (-18.75%)
as of Sep 20, 2019

Last 0.065
Change -0.015 (-18.75%)
Open 0.075
Prev. Close 0.080
Today's Range
0.065
0.075
52wk Range
0.045
0.175
Volume 1,379,575
Avg Volume 510,690

Perfomance Comparison

Name Today 3-Month 1-Year
BCT.VN -18.75% -18.75% -53.57%
$TXCX +0.25% +2.03% +4.22%
$TXSC +0.19% +2.07% +5.23%
DJIA -0.59% -0.56% +1.04%
S&P 500 -0.49% -0.26% +2.09%

Key Statistics

Annual EPS -0.030
Dividend Yield N/A
P/E Ratio N/A
Market Capitalization, $K 13,550
Weighted Alpha -54.39
Standard Deviation -2.24
Profit Margin N/A
Beta 1.227

Growth Rates

YTD -18.75%
1-Year -53.57%
3-Year -69.05%

Opinion

Sell Hold Buy

Recent Headlines

BriaCell Announces Private Placement of up to $600,000

GlobeNewswire via COMTEX - Fri Sep 20, 11:03AM EDT
BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, is pleased to announce a non-brokered p(full story)
BCTXF: 0.0550 (-0.0074), BCT.VN: 0.065 (-0.015), MRK: 85.16 (+1.19)

IIROC Trading Resumption - BCT

CNW Group via COMTEX - Thu Sep 19, 11:29AM EDT
Trading resumes in:(full story)
BCTXF: 0.0550 (-0.0074), BCT.VN: 0.065 (-0.015)

BriaCell Announces Public Disclosure: Remarkable

GlobeNewswire via COMTEX - Thu Sep 19, 10:00AM EDT
Material information is being presented concurrent with this press release at 9:35am Eastern Time at the Next Gen Immuno-Oncology Congress. Publicly-traded securities of BriaCell Therapeutics Corp. (TSX-V:BCT) (OTCQB:BCTXF) will (full story)
BCTXF: 0.0550 (-0.0074), BCT.VN: 0.065 (-0.015), MRK: 85.16 (+1.19)

IIROC Trading Halt - BCT

CNW Group via COMTEX - Thu Sep 19, 09:12AM EDT
The following issues have been halted by IIROC:(full story)
BCTXF: 0.0550 (-0.0074), BCT.VN: 0.065 (-0.015)

BriaCell to Present September 19th at 2nd Annual Next

GlobeNewswire via COMTEX - Mon Sep 16, 06:30AM EDT
BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, today announces that the Company will b(full story)
BCTXF: 0.0550 (-0.0074), BCT.VN: 0.065 (-0.015), MRK: 85.16 (+1.19), INCY: 81.21 (+3.09)